Hepta Medical Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $11.6M

  • Investors
  • 7

Hepta Medical General Information

Description

Developer of a flexible microwave ablation platform designed to introduce minimally invasive nonsurgical treatment for early lung cancer. The company's technology develops an ablation catheter with integrated tissue temperature sensing to allow for real-time monitoring of tissue ablation, enabling healthcare professionals to ablate while controlling the size of the lesion, resulting in more efficient and safer outcomes for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5-11 rue Gardenat Lapostol
  • 92150 Suresnes
  • France
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Biotechnology
Vertical(s)
Corporate Office
  • 5-11 rue Gardenat Lapostol
  • 92150 Suresnes
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hepta Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 31-Mar-2026 $11.6M Completed Generating Revenue
2. Later Stage VC 19-Sep-2022 Completed Generating Revenue
1. Accelerator/Incubator 01-Jun-2019 Completed Startup
To view Hepta Medical’s complete valuation and funding history, request access »

Hepta Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ADP2022
Ordinary
Ordinary 2,202 $0.999801 $227.02 $227.02 0x $227.02 45.75%
To view Hepta Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hepta Medical Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bpifrance Sovereign Wealth Fund Minority
Clery Impact Investing Minority
M&L Group Venture Capital Minority
Supernova Invest Venture Capital Minority
UI Investissement PE/Buyout Minority
You’re viewing 5 of 7 investors. Get the full list »

Hepta Medical FAQs

  • When was Hepta Medical founded?

    Hepta Medical was founded in 2017.

  • Where is Hepta Medical headquartered?

    Hepta Medical is headquartered in Suresnes, France.

  • What industry is Hepta Medical in?

    Hepta Medical’s primary industry is Therapeutic Devices.

  • Is Hepta Medical a private or public company?

    Hepta Medical is a Private company.

  • What is Hepta Medical’s current revenue?

    The current revenue for Hepta Medical is .

  • How much funding has Hepta Medical raised over time?

    Hepta Medical has raised $12.3M.

  • Who are Hepta Medical’s investors?

    Bpifrance, Clery, M&L Group, Supernova Invest, and UI Investissement are 5 of 7 investors who have invested in Hepta Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process